Back to search
FDAFDA · Food and drugs·Recall number D-1445-2016

Bactroban Ointment, (Mupirocin Ointment 2%), 22 gram tube, Rx only, GlaxoSmithKline, Research Triangle Park, NC 27709, Made in England, NDC 0029-1525-44,

Published July 27, 2016 · Recall initiated: July 18, 2016

Summary

FDA records drug Class II recall D-1445-2016, published July 27, 2016 and initiated July 18, 2016. Recalling firm: GlaxoSmithKline, LLC; Status: Terminated; Reported quantity: 18,000 tubes; Lot: Lot #: C715275, Exp. Aug 2016. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Penicillin Cross Contamination

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
GlaxoSmithKline, LLC
Distributor
Nationwide and PR.
Lot
Lot #: C715275, Exp. Aug 2016.
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Bactroban Ointment, (Mupirocin Ointment 2%), 22 gram tube, Rx only, GlaxoSmithKline, Research Triangle Park, NC 27709, Made in England, NDC 0029-1525-44, recalled?

Yes. FDA published recall D-1445-2016 on July 27, 2016. Reported hazard: Penicillin Cross Contamination

What should I do if I have this product?

Voluntary: Firm initiated · Letter